Therapy-related myeloid leukemia during erlotinib treatment in a non-small cell lung cancer patient: A case report

CONCLUSION: Therapy-related acute myeloid neoplasm (t-MN) is a rare but fatal late complication. Although a patient may be taking EGFR-TKIs, the possibility of t-MN should be considered. Further studies are needed to determine whether EGFR-TKI usage is a predisposing factor for t-MN.PMID:34540979 | PMC:PMC8409203 | DOI:10.12998/wjcc.v9.i24.7205
Source: Clinical Lung Cancer - Category: Cancer & Oncology Authors: Source Type: research